← Back to Search

Parental Education for Child Development (CANDO Trial)

N/A
Recruiting
Led By Ruchi S Gupta, MD MPH
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Infant <26 weeks of age at enrollment
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up ≈36 months of age
Awards & highlights

CANDO Trial Summary

This trial will provide parents with education and resources on aspects of infant care including sleep, nutrition, building a healthy relationship with their baby, and healthy screen time use in order to promote healthy development.

Who is the study for?
This trial is for parents/guardians of infants under 26 weeks old who are in good health and can give informed consent in English or Spanish. The family should be willing to follow the study's procedures, not planning to move away before the child turns one year old, and open to being randomly assigned to a group.Check my eligibility
What is being tested?
The study aims to see if providing health education on infant care (like sleep habits, nutrition, bonding with your baby, and screen time) can influence childhood development positively. Parents will be split into two groups: one receiving this intervention and another serving as a control.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments or drugs, there are no direct side effects associated with it. However, changes in routine based on the guidance provided could indirectly affect both the infant's and parent's daily routines.

CANDO Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My baby is younger than 26 weeks old.

CANDO Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~≈36 months of age
This trial's timeline: 3 weeks for screening, Varies for treatment, and ≈36 months of age for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
One year Assessment
Secondary outcome measures
Three year assessment
Two year assessment

CANDO Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: InterventionExperimental Treatment1 Intervention
The intervention group will receive education about nutrition, resources, and specific instructions on promoting healthy development of their infant, including guidance regarding infant sleep, screen time, and building healthy relationships.
Group II: ControlPlacebo Group1 Intervention
The control group will receive specific instructions on promoting healthy development of their infant, including guidance regarding infant sleep, screen time, and building healthy relationships.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intervention
2011
Completed Phase 4
~73780

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,604 Previous Clinical Trials
914,379 Total Patients Enrolled
1 Trials studying Environmental Exposures
Food Allergy Research & EducationOTHER
5 Previous Clinical Trials
29,290 Total Patients Enrolled
Ruchi S Gupta, MD MPHPrincipal InvestigatorNorthwestern University Feinberg School of Medicine

Media Library

Control Clinical Trial Eligibility Overview. Trial Name: NCT05258656 — N/A
Environmental Exposures Research Study Groups: Control, Intervention
Environmental Exposures Clinical Trial 2023: Control Highlights & Side Effects. Trial Name: NCT05258656 — N/A
Control 2023 Treatment Timeline for Medical Study. Trial Name: NCT05258656 — N/A
~720 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top